financetom
AMPH
financetom
/
Healthcare
/
AMPH
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Amphastar Pharmaceuticals, Inc.AMPH
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

The company operates through two segments, Finished Pharmaceutical Products and Active Pharmaceutical Ingredient (API).

It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures.

In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation; and Vasopressin to increase blood pressure in adults with vasodilatory shock.

Further, the company distributes recombinant human insulin APIs and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices.

The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Latest News >
Los Angeles seaport June imports rebound as tariff worries loom over US holiday season
Los Angeles seaport June imports rebound as tariff worries loom over US holiday season
Jul 14, 2025
LOS ANGELES (Reuters) -Imports to the busiest U.S. seaport in Los Angeles rebounded strongly in June as retailers moved to stock up on goods for the holiday shopping season amid fears of higher tariffs. The Port of Los Angeles handled 470,450 20-foot equivalent units (TEUs) of incoming cargo last month after the U.S. reached a tariff truce with China. That...
Market Chatter: Broadcom Cancels Plan to Build $1 Billion Microchip Factory in Spain
Market Chatter: Broadcom Cancels Plan to Build $1 Billion Microchip Factory in Spain
Jul 14, 2025
02:42 PM EDT, 07/14/2025 (MT Newswires) -- Broadcom ( AVGO ) canceled a plan to build a microchip factory in Spain after negotiations with the government collapsed, Spanish news agency Europa Press reported Sunday, citing sources familiar with the situation. The company announced plans to build the large-scale semiconductor factory in 2023, which would have involved a potential investment of...
Presidio Property Trust Prices $2.05 Million Direct Offering
Presidio Property Trust Prices $2.05 Million Direct Offering
Jul 14, 2025
02:45 PM EDT, 07/14/2025 (MT Newswires) -- Presidio Property Trust ( SQFT ) said Monday it has struck a deal to sell 170,830 shares at $12.00 per share to a single institutional investor. The firm said it plans to use the net proceeds for working capital and general corporate purposes. The offering is set to close July 15, with A.G.P./Alliance...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved